» Articles » PMID: 24748411

Physiologically Realistic and Validated Mathematical Liver Model Reveals [corrected] Hepatobiliary Transfer Rates for Gd-EOB-DTPA Using Human DCE-MRI Data

Overview
Journal PLoS One
Date 2014 Apr 22
PMID 24748411
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Diffuse liver disease (DLD), such as non-alcoholic fatty liver disease (NASH) and cirrhosis, is a rapidly growing problem throughout the Westernized world. Magnetic resonance imaging (MRI), based on uptake of the hepatocyte-specific contrast agent (CA) Gd-EOB-DTPA, is a promising non-invasive approach for diagnosing DLD. However, to fully utilize the potential of such dynamic measurements for clinical or research purposes, more advanced methods for data analysis are required.

Methods: A mathematical model that can be used for such data-analysis was developed. Data was obtained from healthy human subjects using a clinical protocol with high spatial resolution. The model is based on ordinary differential equations and goes beyond local diffusion modeling, taking into account the complete system accessible to the CA.

Results: The presented model can describe the data accurately, which was confirmed using chi-square statistics. Furthermore, the model is minimal and identifiable, meaning that all parameters were determined with small degree of uncertainty. The model was also validated using independent data.

Conclusions: We have developed a novel approach for determining previously undescribed physiological hepatic parameters in humans, associated with CA transport across the liver. The method has a potential for assessing regional liver function in clinical examinations of patients that are suffering of DLD and compromised hepatic function.

Citing Articles

DCE-MRI Detects OATP-expressing Transplanted Cells Using Clinical Doses of Gadolinium Contrast Agent.

Bhattacharyya T, Mallett C, Hix J, Shapiro E Mol Imaging Biol. 2025; .

PMID: 39904956 DOI: 10.1007/s11307-025-01986-6.


A proof-of-concept pipeline to guide evaluation of tumor tissue perfusion by dynamic contrast-agent imaging: Direct simulation and inverse tracer-kinetic procedures.

Vignon-Clementel I, Jagiella N, Dichamp J, Kowalski J, Lederle W, Laue H Front Bioinform. 2023; 3:977228.

PMID: 37122998 PMC: 10135870. DOI: 10.3389/fbinf.2023.977228.


Use of In Vivo Imaging and Physiologically-Based Kinetic Modelling to Predict Hepatic Transporter Mediated Drug-Drug Interactions in Rats.

Melillo N, Scotcher D, Kenna J, Green C, Hines C, Laitinen I Pharmaceutics. 2023; 15(3).

PMID: 36986758 PMC: 10057977. DOI: 10.3390/pharmaceutics15030896.


Mathematical models for biomarker calculation of drug-induced liver injury in humans and experimental models based on gadoxetate enhanced magnetic resonance imaging.

Karlsson M, Simonsson C, Dahlstrom N, Cedersund G, Lundberg P PLoS One. 2023; 18(1):e0279168.

PMID: 36608050 PMC: 9821424. DOI: 10.1371/journal.pone.0279168.


Application of Magnetic Resonance Imaging in Liver Biomechanics: A Systematic Review.

Seyedpour S, Nabati M, Lambers L, Nafisi S, Tautenhahn H, Sack I Front Physiol. 2021; 12:733393.

PMID: 34630152 PMC: 8493836. DOI: 10.3389/fphys.2021.733393.


References
1.
Utsunomiya T, Shimada M, Hanaoka J, Kanamoto M, Ikemoto T, Morine Y . Possible utility of MRI using Gd-EOB-DTPA for estimating liver functional reserve. J Gastroenterol. 2011; 47(4):470-6. DOI: 10.1007/s00535-011-0513-8. View

2.
Shuter B, Tofts P, Wang S, Pope J . The relaxivity of Gd-EOB-DTPA and Gd-DTPA in liver and kidney of the Wistar rat. Magn Reson Imaging. 1996; 14(3):243-53. DOI: 10.1016/0730-725x(95)02097-d. View

3.
Kirkpatrick S, Gelatt Jr C, Vecchi M . Optimization by simulated annealing. Science. 1983; 220(4598):671-80. DOI: 10.1126/science.220.4598.671. View

4.
Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann H . Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol. 2005; 40(11):715-24. DOI: 10.1097/01.rli.0000184756.66360.d3. View

5.
Gschwend S, Ebert W, Schultze-Mosgau M, Breuer J . Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment. Invest Radiol. 2011; 46(9):556-66. DOI: 10.1097/RLI.0b013e31821a218a. View